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Lipid proﬁleJaboticaba (Myrciaria jaboticaba (Vell.) Berg) is a Brazilian Atlantic rainforest fruit of theMyrtaceae family. In this
work, the effect of the daily intake (40 days) of jaboticaba (1.0 and 2.0 g dry weight/kg body weight) on oxida-
tive stress and plasma lipid proﬁle of streptozotocin (STZ)-induced diabetic rats was evaluated. Jaboticaba was
shown to be a good source of phenolic compounds, proanthocyanidins and ellagitannins. Daily administration
of jaboticaba resulted in ameliorated water consumption and energy intake in STZ-diabetic rats. Plasma total
cholesterol levelswere reduced in 32% and triacylglycerol decreased 50%whenboth doses of jaboticabawere ad-
ministered. This reduction of total cholesterol and triacylglycerol levels seems to be associated to the strong in
vitro inhibition of pancreatic lipase presented by jaboticaba extracts. Plasma antioxidant capacity of diabetic
rats assessed by ferric reducing ability of plasma (FRAP) assay increased (2 to 2.5 times) after supplementation
with both doses of jaboticaba along with a decrease of lipid peroxidation in plasma (22%) and brain (10–17%).
Diabetic rats consuming jaboticaba presented higher activity of superoxide dismutase in the brain, catalase
and glutathione peroxidase (GPx) in the kidneys and liver, and GPx in plasma, as compared to the control
group. These results suggest that daily ingestion over a period of 40 days of jaboticaba may represent a dietary
strategy for controlling oxidative stress in pathological conditions.
© 2013 Elsevier Ltd. All rights reserved.1. Introduction
Jaboticaba, Myrciaria jaboticaba (Vell.) Berg, is a Brazilian native
fruit from the Atlantic rainforest that belongs to the Myrtaceae family,
grape-like in appearance and texture. Its economic importance has
been continuously growing in Brazil because of the sweet and slightly
acidic ﬂavor of the pulp. Jaboticaba has a huge trading potential, since
it can be consumed in natura and also used by industry as ingredient
to produce cosmetics and food products (Donadio, 2000).
Jaboticaba fruits are a rich source of polyphenols, such as anthocy-
anins, which are concentrated in the dark purple to almost black skin,
when the fruit is ripe, besides quercetin derivatives and proantho-
cyanidins. Furthermore, a recent study carried out with two species
of jaboticaba proved ellagic acid derivatives, such as ellagitannins,
are the main compounds detected in jaboticaba (Alezandro, Dubé,
Desjardins, Lajolo, and Genovese, 2013). Long-term ingestion of fruits
with high levels of ﬂavonoids (anthocyanins) and tannins (ellagitannins)
has been associated with positive effects on human health, related to
their antioxidant potential and consequent inhibitory activity against+55 11 38154410.
rights reserved.lipid peroxidation, reducing the risk of cardiovascular diseases (Mullen
et al., 2002; Priyadarsini, Khopde, Kumar, and Mohan, 2002; Srinivasan,
Vadhanam, Arif, and Gupta, 2002). Despite the unclear mechanisms
and few studies reported, several hypotheses indicate that the high anti-
oxidant capacity of phenolic compounds, especially ﬂavonoids, may also
be effective in reducing oxidative stress (Macedo et al., 2013), progres-
sion of diabetes mellitus (Song, Wang, Li, and Cai, 2005), and hyperten-
sion (Kwon, Vattem, and Shetty, 2006).
Streptozotocin-induced diabetes is an animalmodel used to promote
metabolic dysfunctions related to oxidative stress (Raza and John,
2012). Oxidative stress occurs when there is an overproduction of free
radicals and the endogenous antioxidants are not enough to buffer
these unstable molecules (Mullarkey, Edelstein, and Brownlee, 1990),
and leads to modiﬁcations involved in the inﬂammation process and
in the initiation and progression of atherosclerosis (Strobel, Fassett,
Marsh, and Coombes, 2010), thus being intrinsically linked with
non-transmissible chronic diseases (Mullarkey et al., 1990).
Studies about the potential beneﬁcial effect on health of jaboticaba
are sparse, but research has shown that native fruits are promising
sources of bioactive compounds. Herein, the research available in the
literature mostly focused on the role of anthocyanins present in the
skin of the fruit (Dragano et al., 2013; Lenquiste, Batista, Marineli,
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and importance of ellagitannins. Based on these considerations, this
work aimed to evaluate the effects of daily administration over a period
of 40 days of whole jaboticaba on the oxidative stress related to
streptozotocin-induced diabetes in an animal model using Wistar rats.
2. Material and methods
2.1. Chemicals
The hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox)
was obtained from Aldrich (Milwaukee, WI, USA). Malondialdehyde,
ﬂuorescein, 2,2-azobis(2-methylpropionamide) dihydrochloride (AAPH),
xanthine oxidase (from bovine milk), cytochrome c (from horse heart)
and xanthine were purchased from Sigma Chemical Co. (St Louis, MO,
USA). Glutathione, glutathione reductase and nicotinamide adenine di-
nucleotide phosphate (NADPH) were obtained from Merck Chemical
Co. (Darmstadt, Germany). TPTZ (2,4,6-tripyridyl-S-triazine) was pur-
chased from Fluka Chemie AG (Buchs, Switzerland). Ketamine chloride
andxylidine chloridewere acquired fromBayer (Leverkusen, Germany).
All chemicals/solventswere of analytical or HPLC grade, according to the
requirement.
2.2. Samples
Fully ripened jaboticaba Sabará (M. jaboticaba Vell. Berg) was
obtained from a local producer at the São Paulo Central Market
(Companhia de Entrepostos e Armazéns Gerais de São Paulo— CEAGESP,
Brazil). Fruits were cleaned and immediately freeze-dried and stored at
−20 °C. Then, the dried fruits were ground to a ﬁne powder in a mortar
and pestle, using liquid nitrogen to keep the sample frozen. Protein, lipid,
ﬁber and ash contents of jaboticaba were assessed according to AOAC
(2005). Total phenolics (Singleton, Orthofer, and Lamuela-Raventos,
1999), proanthocyanidins (Porter, Hrstich, and Chan, 1986), ellagitannins
(Pinto, Lajolo, and Genovese, 2008) and total tannins (Hagerman and
Butler, 1978) were also determined. Results were expressed as mg/g
fresh weight (FW).
2.3. Sample extraction for lipase inhibition assay
Samples were extracted in a 70% aqueous methanol solution for
2 h at room temperature, at a 1:20 (w/v) ratio of sample-to-solvent.
After ﬁltration (Whatman no. 1), extracts were kept at −80 °C until
analyses (Arabbi, Genovese, and Lajolo, 2004).
2.4. Measurement of pancreatic lipase activity
The pancreatic lipase activity was measured using 4-methylumbel-
liferyl oleate (4-MU oleate) as a substrate, according to Jacks and
Kircher (1967) with some modiﬁcations (You, Chen, Wang, Jiang, and
Lin, 2012). Twenty-ﬁve microliters of a sample solution dissolved in
water and 50 μL of a 0.1 mM 4-MU solution dissolved in a buffer con-
sisting of 13 mM Tris–HCl, 150 mM NaCl, and 1.3 mM CaCl2 (pH 8.0)
were mixed in the well of a microtiter plate, and 25 μL of the lipase
solution (50 U/mL) in the above buffer was then added to start the
enzyme reaction. After incubation at 25 °C for 30 min, 0.1 mL of 0.1 M
sodium citrate (pH 4.2) was added to stop the reaction. The amount
of 4-methylumbelliferone released by lipase was measured with a
ﬂuorometrical microplate reader (Fluoroskan Ascent C LabSystems,
Inc.) at an excitation wavelength of 355 nm and an emission wave-
length of 460 nm. Results were expressed as IC50 values, considering
the amount of sample (mg sample DW/mL reaction) and the content
of phenolic compounds (mg catechin equivalents (CE)/mL reaction),
determined according to Singleton et al. (1999).2.5. Animals and experimental design
The Faculty of Pharmaceutical Sciences/USP Ethical Committee
for Animal Research approved all the adopted procedures (Protocol
CEUA/FCF/USP no. 355). Thirty six male rats weighing 200 ± 10 g
were obtained fromAnimal House of Faculty of Pharmaceutical Sciences
and Chemistry Institute of University of São Paulo. Animals were kept
under standard laboratory conditions of temperature (23 ± 2 °C), rela-
tive humidity (50 ± 5%), and 12 h light–dark cycle. Chow diet and
water were provided ad libitum. For diabetes induction, overnight
fasted rats received intraperitoneal injection (i.p.) of STZ (65 mg/kg)
in citrate buffer (pH 4.5), followed by an aqueous solution of 10% glu-
cose for 8 h. After three days glycemia was measured and all rats
presented glucose levels higher than 200 mg/dL. The STZ-diabetic ani-
mals were divided into three groups of 12 animals, as follows:
— Control: animals receiving water by gavage during 40 days;
— Group 1: animals receiving 1.0 g/kg body weight of jaboticaba
powder dispersed in water, by gavage, during 40 days;
— Group 2: animals receiving 2.0 g/kg body weight of jaboticaba
powder dispersed in water, by gavage, during 40 days.
The administration of freeze-dried jaboticaba dispersed in water
(or just water, in the control group) was done once a day, by gavage.
The doses (1.0 or 2.0 g/kg body weight) were adjusted considering
the actual weight of each animal. The food and water consumptions
were recorded daily, and the animals were weighted every three
days. The fasting blood glucose (collected from the caudal vein) was
measured every ﬁve days in all animals, totaling to eightmeasurements
(Supplement Fig.). For the ﬁnal measurement, plasma obtained from
the blood collected by euthanasia was used. Results were reported as
average energy intake (kcal/day),water consumption (mL/day), plasma
glucose levels (mg/dL) and body weight (g) for the 40 days period.
2.6. Blood and tissue samples
After 40 days the animals were anesthetized with ketamine chlo-
ride and xylidine chloride. Blood was collected by cardiac puncture
into tubes containing EDTA. The plasma was separated by centrifuga-
tion at 2000 g for 10 min at 4 °C. Erythrocytes were washed three
times with ice-cold 9 g/L NaCl solution and hemolyzed with distilled
water (1:4 v/v). The tissues were exhaustively perfused with steril-
ized ice-cold 9 g/L NaCl solution through heart puncture until the
liver was uniformly pale. The kidneys, brain and liver were removed,
weighed and immediately frozen under liquid nitrogen and stored at
−80 °C for further biochemical analysis. At the time of analysis, the
tissue homogenates were prepared with ice-cold 50 mM phosphate
buffer (pH 7.4) (1:4 w/v) and centrifuged at 10,000 g for 10 min at
4 °C.
2.7. Plasma antioxidant capacity
Antioxidant capacity of plasma towards peroxyl radicals was eval-
uated by the ORAC method as described by Huang, Ou, Hampsch-
Woodill, Flanagan, and Prior (2002) and the ferric reducing ability
of plasma (FRAP) assay was determined according to Benzie and
Strain (1996). Both methods were performed on a Synergy H1 Hybrid
Multi-Mode microplate reader (BioTek Instruments, Winooski, VT)
and the results were expressed in μmol Trolox equivalents (TE)/mL
plasma.
2.8. Lipid peroxidation levels
Thiobarbituric acid reactive substance (TBARS) levels in plasma
and tissues were measured according to Ohkawa, Ohishi, and Yagi
(1979). An aliquot of plasma or tissue homogenate was mixed with
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turic acid and water. The mixture was heated for 1 h at 95 °C and the
pink chromogen formed was extracted into 1.4 mL of n-butanol. The
absorbance of the organic phase was measured at 532 nm using a
Synergy H1 Hybrid Multi-Mode microplate reader (BioTek Instru-
ments, Winooski, VT). Malondialdehyde (MDA) was used as a stan-
dard. Results were expressed as ηmol MDA/mL plasma or mg protein.
2.9. Antioxidant enzymes
Antioxidant enzyme activities were measured in plasma and tis-
sues (liver, brain and kidney). Brieﬂy, catalase (CAT) activity was
assayed at 25 °C by a method based on the disappearance of 10 mM
H2O2. The decomposition of H2O2 by CAT contained in the samples
follows a ﬁrst-order kinetic and changes in absorbance were mea-
sured 60 s after addition of H2O2, and then at 60 s intervals over
4 min (Hugo and Lester, 1984). Glutathione peroxidase (GPx) cataly-
ses the oxidation of glutathione by tert-butyl hydroperoxide. In the
presence of glutathione reductase and NADPH, the oxidized glutathi-
one is converted to the reduced form with a concomitant oxidation of
NADPH to NADP+, which is reﬂected as a decrease in the absorbance
at 340 nm (ε340 6.22 L/mmol/cm). Changes in absorbance were
measured at 60 s intervals over 6 min (Albrecht and William, 1981).
Superoxide dismutase (SOD) activity was measured by the decrease
in the rate of cytochrome c reduction in a xanthine/xanthine oxidase
superoxide-generating system consisting of 10 mM cytochrome c,
100 mM xanthine, 50 mM sodium phosphate buffer (pH 7.8) and
the necessary quantity of xanthine oxidase to yield a variation of
0.025 absorbance/min at 550 nm (Gunzler et al., 1984). Enzymatic
activities were expressed as units of activity (UA, corresponding to
0.1 absorbance changes for CAT and GPx and to 0.0125 absorbance
change for SOD) min−1.g−1.protein or mg−1 hemoglobin (Hb). Pro-
tein concentration in plasma samples was determined by the method
described by Lowry, Rosebrough, Farr, and Randall (1951). Hemoglo-
bin was measured using Drabkin's reagent.
2.10. Biochemical analysis
The concentrations of total cholesterol (TC), triacylglycerol (TAG),
HDL cholesterol (HDL-c), glucose, urea and creatinine in plasma were
determined using commercial kits Labtest (Lagoa Santa, MG, Brazil).
The fasting blood glucose was determined by means of the Accu-
Chek Performa® system.
2.11. Statistical analysis
Data were presented as mean ± SD. Initially, the results were
checked for homogeneity of variances by using the Levene test
while one-way ANOVA (parametric) or theWelch test (non-parametric)
was used to assess the differences among the three treatments. The least
signiﬁcant difference Fisher test or Kruskal–Wallis test was used toTable 1
Chemical composition (mg/g FW) and in vitro inhibitory activity of pancreatic lipase (IC50)
Nutritional composition
Chemical composition
Carbohydratea Proteina Lipida Ashesa Fibera
138 ± 5 1.7 ± 0.1 0.72 ± 0.02 5.2 ± 0.2 35 ± 2
Inhibitory activity of pancreatic lipase
IC50 (mg sample DW/mL reaction)
1.08
a Contents expressed as mg/g FW.
b mg catechin equivalent/g FW.
c mg quebracho tannin/g FW.
d mg ellagic acid/g FW.
e mg tannic acid/g FW.compare the means within groups. p-Values below 0.05 were regarded
as signiﬁcant. In order to observe the experimental results simultaneous-
ly, nine biomarkers (triacylglycerol, total cholesterol, GPx liver, TBARS
brain, TBARS plasma, CAT liver, SOD plasma, SOD brain, ORAC plasma)
were submitted to a principal component analysis, adopting the bio-
markers as columns andWistar rats as cases. Analyseswere based on lin-
ear correlation, variances were computed as Sum of Squares / (n − 1)
and a scatter plot that contained the variables and rats was built
adopting the factor-plane (1 × 2) (Granato, Katayama, and Castro,
2012). Statistical standardization was performed to obtain relativized
data to which the multivariate technique was applied. The standardiza-
tion of the variables was performed using Eq. (1):
Zij ¼
Xij−X J
sj
ð1Þ
where Z is the standardized value for each value of the response, Xij
represents the original value for the object (i) of measured attribute
(j), X J is the mean value of variable j, and sj is the standard deviation for
the attribute. All statistical analyses were performed with STATISTICA v.
11 software (StatSoft Inc., Tulsa, OK, USA).
3. Results
Jaboticaba was shown to be a good source of phenolic compounds,
which included proanthocyanidins (10.4 mg/g FW), ellagitannins
(9.1 mg/g FW) and total tannins (7.3 mg/g FW). Besides being rich
in polyphenols, jaboticaba provides ﬁbers (34.7 mg/g FW), ashes
(5.2 mg/g FW), and important nutrients in maintaining health (Table 1).
Besides, jaboticaba raw extract showed a strong inhibitory activity
against pancreatic lipase (IC50 = 1.08 mg sample/mL reaction) and its
polyphenols largely contributed to this effect (IC50 = 0.06 mg CE/mL)
(Table 1).
Here, it was demonstrated that the daily administration of jaboti-
caba was effective for controlling oxidative stress and hyperlipidemia
in STZ-diabetic rats. Polyphagia and polydipsia (Fig. 1), common
symptoms of diabetic animals, were also assuaged when the diabetic
rats received both doses of jaboticaba. The mean energy intake was
signiﬁcantly reduced (p b 0.01) in 6%, after administration of the low-
est dose, and 13% for the highest dose. Similarly, signiﬁcant (p b 0.01)
reductions of 8% and 14% in water consumption were observed after
treatment with 1 and 2 g DW (dry weight)/kg of jaboticaba, respec-
tively. However, an increase (p = 0.03) in blood glucose levels was
detected after administration of the highest dose of jaboticaba (Fig. 1),
not physiologically relevant due to the already elevated glycemia of
the animals (N680 mg/dL).
The mean body weight of the diabetic rats treated with both doses
of jaboticaba was not signiﬁcantly different from the control rats.
However, the weight of the liver in proportion to the body weight
was lower (p b 0.01) in the treated groups (5.3–5.9%) compared to
the untreated animals (7.1%), a 21% decrease (Fig. 2).of jaboticaba berry.
Polyphenol composition
Total phenolicb PACsc ETsd Total tanninse
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Fig. 1. (A)Water consumption (mL/day), (B) energy intake (kcal/day) and (C) plasma glu-
cose levels (mg/dL) of STZ-diabetic rats fed ad libitumwith chow diet and receiving jaboti-
caba for 40 days by gavage. Values were expressed as mean ± SD (n = 12 rats/group).
Different letters above the columns indicate statistical difference. The p value between
supplemented and control groups was expressed as * (p b 0.05) and ** (p b 0.01).
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the administration of jaboticaba was able to recover lipid levels in
diabetic rats. Plasma TAG (p b 0.01) and TC (p b 0.01) levels were re-
duced in the treated groups (Fig. 3). TAG was reduced in 50% and TC
in 32% for both doses of jaboticaba.
The two important indicators of renal health were evaluated. Cre-
atinine varied from 0.73 to 0.97 mg/dL, and urea ranged between 61
and 67 mg/dL. No effect (p N 0.05) was observed after administration
of jaboticaba during 40 days, compared to the control with treated
groups (Fig. 4).
Antioxidant capacity and lipid peroxidation are two of the most rel-
evant parameters of oxidative stress. Antioxidant capacity assessed by
FRAP assay signiﬁcantly increased (p b 0.01) from 4.5 μmol TE/mL
plasma in the control rats to 12.1 μmol TE/mL plasma in the treated
rats from Group 1, which represents a 2.5 fold increase. For the group
that received the highest dose of jaboticaba, antioxidant capacity
was 2-fold higher than in the control rats. Conversely, no signiﬁcant
(p = 0.53) effect in the antioxidant capacity assessed by ORACwas ob-
served after treatment (Fig. 5).
High concentration of MDA in tissues and/or in plasma is a known
biomarker of oxidative damage. Untreated diabetic rats showed
elevated levels of MDA in both plasma and brain, when comparedto treated groups (Fig. 5). Daily administration of jaboticaba signiﬁ-
cantly decreased lipid peroxidation in plasma (p b 0.01) and brain
(p = 0.01), although no effect was observed in the liver (p = 0.07)
and kidney (p = 0.54). Our ﬁndings suggest that polyphenols from
jaboticaba protected the STZ-diabetic rats against oxidative damage.
The activities of enzymatic antioxidants (SOD, CAT, GPx) were eval-
uated in plasma and tissues. SOD activity in the brain of treated diabetic
rats increased signiﬁcantly (about 55%) as compared to the control rats
(p = 0.001). Administration of jaboticaba to STZ-induced diabetic rats
signiﬁcantly increased (p b 0.01) or restored the CAT and GPx activities
in the kidney and liver. In plasma, GPx activity was 25% higher after
treatment with the highest dose of jaboticaba than observed in control
rats (Fig. 6).
A multivariate approach using principal component analysis was
proposed (Fig. 7). By analyzing the results, a total of 63.60% of data var-
iability was explained by the ﬁrst two principal components. It is possi-
ble to observe that rats treated with jaboticaba (Group 1 and Group 2)
were separated from the control groupusing the nine selected oxidative
stress biomarkers as responses, indicating that the supplementation
was effective and this in vivomodel was suitable to assess the oxidative
stress and lipid proﬁle of STZ-induced diabetic Wistar rats treated with
jaboticaba. The control group was separated from both Group 1 and
Group 2 due to differences (higher contents) in cholesterol, triacylglyc-
erols, TBARS (brain and plasma), and also because of low of activity of
CAT (liver) and GPx (liver). In a comparison between the two experi-
mental groups, Group 1 was separated from Group 2 based on its
lower activity of SOD (plasma) and CAT (liver) and higher antioxidant
capacity of plasma (ORAC) and activity of SOD (brain).
4. Discussion
Experimental models carried out with the use of diabetic animals
have demonstrated that oxidative stress, caused by persistent hyper-
glycemia, impairs the antioxidant defense system and generates reac-
tive oxygen species by auto-oxidation of glucose. In experiments with
streptozotocin-induced diabetes, both hyperglycemia and oxidative
stress are involved in the etiology and pathology of disease-related
complications (Baynes and Thorpe, 1997).
Streptozotocin acts as causing damage to DNA, after entering into
the β-cells via GLUT 2, a glucose transporter. The alkylation of DNA in-
duces activation of poly ADP-ribosylation,which ismore relevant for di-
abetes induction than DNA damage itself. Poly ADP-ribosylation brings
on depletion of cellular NAD+ and ATP, providing a substrate for xan-
thine oxidase, which results in the formation of superoxide radicals. Hy-
drogen peroxide and hydroxyl radicals are also generated, thereafter.
Moreover, streptozotocin releases high amounts of nitric oxide, which
is toxic and inhibits aconitase activity and participates in DNA damage.
β-Cells undergo the destruction by necrosis, as a consequence of the
streptozotocin action (Szkudelski, 2001).
Many fruits belonging to the Myrtaceae family have displayed an
important role in controlling the oxidative stress damage related to
chronic diseases, such as diabetes, in animal model. Organic extracts
from Psidium guajava Linn. and Eugenia jambolana were shown to
protect against lipid peroxidation in tissue (islet β-cells) and restore
the activities of antioxidant enzymes, including GPx, CAT, and SOD,
as well as to ameliorate plasma lipid proﬁle and hyperglycemia
(Huang, Yin, and Chiu, 2011; Sharma, Balomajumder, and Roy, 2008).
Jaboticaba also belongs to the Myrtaceae family and among the
Braziliannative fruits it is themost popular and largely studied in recent
years. It is very attractive not only because of the distinctﬂavor and high
production and commercialization, but also due to its singular chemical
composition (Abe et al., 2012). Our ﬁndings showed that jaboticaba is
rich in phenolic compounds, mainly proanthocyanidins, ellagic acid
derivatives and tannins. Previous results demonstrated that a high con-
centration of anthocyanins is present in the skin of the fruit (Alezandro
et al., 2013). Being an important source of awide variety of polyphenols,
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Fig. 2. (A) Bodyweight (g) and tissueweight (% bodyweight), liver (B), brain (C) and kidneys (D) of STZ-diabetic rats fed ad libitumwith chow diet and receiving jaboticaba for 40 days
by gavage. Values were expressed as mean ± SD (n = 12 rats/group). Different letters above the columns indicate statistical difference. The p value between supplemented and control
groups was expressed as * (p b 0.01).
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this study were evaluated.
Alterations caused by STZ are very well established (Lenzen, 2008;
Szkudelski, 2001). Here the objectives were to evaluate the effect of
jaboticaba under pathological stress, and in this way only animals
presenting glucose levels higher than 200 mg/dL were selected to
be supplemented. Results from the literature consistently demon-
strate that, besides hyperglycemia, there is an increase in triacylglyc-
erol and total cholesterol levels in plasma and high concentrations of
thiobarbituric acid reactive substances in the liver and kidneys. In
these tissues, the weight of the organ in proportion to the body
weight is also increased (Silva, Lima, Silva, and Pedrosa, 2011).
In diabetes, polyuria, polyphagia andpolydipsia are usual symptoms,
which are evident since the beginning of the disease. Polyphagia is asso-
ciated with the absence or resistance to insulin action that hinders glu-
cose entry into the cells. Additionally, hyperglycemia is responsible for
blood hyperosmolarity, which causes an osmotic dieresis, known as
polyuria. Consequently, there is an excessive loss of water leading to de-
hydration and activation of the thirst center, resulting in polydipsia
(Okon, Owo, Udokang, Udobang, and Ekpenyong, 2012). The chronic
administration of jaboticaba ameliorates those symptoms, reducing
the water and energy intakes after 40 days of supplementation.
However, since the cell injuries caused by STZ are irreversible, the
treatment with jaboticaba was not able to recover the β-cells and in-
sulin secretion, being difﬁcult to control hyperglycemia (Szkudelski,
2001). Moreover, diabetes also leads to a signiﬁcant weight loss related
to the incapability of cells to produce energy from glucose. Once gluco-
neogenesis is activated, muscle protein and fats are excessively mobi-
lized for energy production, which contributes for the weight loss,
along with the dehydration caused by polyuria (Okon et al., 2012). Anincrease in the weight of the liver in proportion to the body weight
(liver to body weight ratio) is also usual (Maritim, Dene, Sanders, and
Watkins, 2003a), and although jaboticaba administration had no effect
(p N 0.05) on weight during 40 days, this ratio was reduced from 7.1%
in the control groups to 5.3–5.9% in the treated rats, a 21% decrease.
Lipids play an important role in the development of diabetes, and
increased concentrations of lipids in plasma represent a risk factor for
coronary heart diseases (He and King, 2004). The reduction of total cho-
lesterol and triacylglycerol levels could be related to the biological activ-
ities of jaboticaba polyphenols, whichwere shown to be responsible for
inhibition of pancreatic lipase, a key enzyme for lipid absorption. It is
well-known that pancreatic lipase is responsible for dietary fat break-
down before it could be absorbed from the intestine (McDougall,
Kulkarni, and Stewart, 2009). Hypercholesterolemia in animals that re-
ceived streptozotocin is caused by a higher intestinal absorption and in-
creased cholesterol biosynthesis (Silva et al., 2011). The lipoproteins in
diabetic rats are oxidized and may be cytotoxic, which is reversed by
treatment with antioxidants (Mathé, 1995). Our results demonstrated
that jaboticaba recovered lipid proﬁle of diabetic rats, reducing both tri-
acylglycerol and total cholesterol concentrations in plasma.
Besides the effect of jaboticaba polyphenols with antioxidant ac-
tivity, ﬁbers are essential dietary components closely related to the
beneﬁcial effects observed in this study. In diabetic conditions, ﬁbers
in jaboticaba may stimulate short-chain fatty acid production, which
enhance glucose oxidation, reduce free fatty acid release and improve
insulin sensitivity. In addition, the synthesis of glucagon like-peptide
1 (GLP-1) can be induced, which is responsible for delaying gastric
emptying, increasing insulin-dependent cellular uptake of glucose,
inhibiting glucagon secretion, stimulating insulin secretion and re-
ducing hepatic glucose production, which collectively may act to
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Fig. 3. Plasma lipid proﬁle (mg/dL) of STZ-diabetic rats fed ad libitumwith chow diet and
receiving jaboticaba for 40 days by gavage: (A) total cholesterol, (B) triacylglycerol, and
(C) HDL-cholesterol. Values were expressed as mean ± SD (n = 12 rats/group). Differ-
ent letters above the columns indicate statistical difference. The p value between
supplemented and control groups was expressed as * (p b 0.01).
Fig. 4. Plasma creatinine (A) and urea (B) concentrations (mg/dL) of STZ-diabetic rats
fed ad libitum with chow diet and receiving jaboticaba for 40 days by gavage: (A) total
cholesterol, (b) triacylglycerol, and (c) HDL-cholesterol. Values were expressed as
mean ± SD (n = 12 rats/group). Different letters above the columns indicate statistical
difference.
655M.R. Alezandro et al. / Food Research International 54 (2013) 650–659reduce the requirement for insulin (Galisteo, Duarte, and Zarzuelo,
2008). Moreover, ﬁbers can have positive effects on hypercholesterol-
emia, mainly by decreasing low-density lipoprotein (LDL-C) without
affecting high-density lipoprotein cholesterol (HDL-C), as a conse-
quence ofmodulation of bile acids and lipid absorption andmetabolism.
Reducing the absorption of bile acids and cholesterol, fecal sterol excre-
tion will be enhanced (Jenkins, Wolever, Rao, et al., 1993; Theuwissen
andMensink, 2008). Minerals, as well as vitamins, have also been asso-
ciated with beneﬁcial effects on dyslipidemia associated with diabetes,
increasing serum concentrations of HDL cholesterol and apolipoprotein
A-1 (Farvid, Siassi, Jalali, Hosseini, and Saadat, 2004).
Nephropathy is one of the most severe complications of diabetes
and often leads to end-stage chronic renal failure. Diabetic individuals
usually have high contents of nitrogen compounds in plasma andurine, such as creatinine and urea, as a result of decreased protein syn-
thesis and increasedmuscle proteolysis (Gray and Cooper, 2011). In this
study, no effect was observed in the concentrations of creatinine and
urea in plasma, and these data are similar to the results obtained by
Oliveira and Genovese (2013) after treating STZ-diabetic rats with
cupuassu and cocoa liquors.
Indeed, antioxidant capacity is decreased in the plasma of untreated
diabetic animals, as a consequence of a higher requirement of antioxi-
dants to regulate the ROS homeostasis (Posuwan et al., 2013). However,
increased plasma antioxidant capacity along with reduced lipid peroxi-
dation could be achieved after regular intake of rich sources of antioxi-
dant compounds (Torabian, Haddad, Rajaram, Banta, and Sabaté, 2009).
Anthocyanins, such as cyanidin-3-O-glucoside and delphinidin-3-
O-glucoside, found in jaboticaba skin, were shown to be responsible
for an increase in the antioxidant capacity of plasma in an animal
model (Leite et al., 2011). Ellagic acid, in addition, can inhibit ROS for-
mation (Larrosa, García-Conesa, Espín, and Tomás-Barberán, 2010).
Quercetin prevents oxidant injury and cell death by scavenging oxygen
radicals, protecting against lipid peroxidation and by chelating metal
ions (Coskun, Kanter, Korkmaz, and Oter, 2005).
ROS can be initially eliminated by essential scavenger enzymes,
such as superoxide dismutase (SOD), catalase (CAT) and glutathione
peroxidase (GPx) (Posuwan et al., 2013). When the activity of these
antioxidant enzymes is reduced, the superoxide anion and hydrogen
peroxide are exceedingly available in biological systems, stimulating
the ROS production and the propagation of lipid peroxidation. Gener-
ally, the tissues of diabetic individuals showed decreased CAT activity
(Posuwan et al., 2013). Hepatic SOD and GPx are also affected by in-
creasing ROS generation and their activities are diminished, which
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656 M.R. Alezandro et al. / Food Research International 54 (2013) 650–659were conﬁrmed by our results. The effect of exogenous antioxidants,
such as polyphenols from jaboticaba, would change according to the
intervention period, in other words, if the administration started be-
fore the diabetes induction, concomitantly or after well-established
diabetes (Maritim, Sanders, and Watkins, 2003b).
Results from the literature consistently demonstrate that the ac-
tivities of antioxidant enzymes can be differently affected by dietary
administration of phenolics, depending on the tissue considered and
physiopathological condition. We previously showed that isoﬂavones
even caused a decrease in SOD activity in the liver, which could be a
compensation for the increased antioxidant capacity of the plasma,
in normal condition (Barbosa, Lajolo, and Genovese, 2011). Minerals
and vitamins may also be effective in reducing malondialdehyde
(MDA), and modulating the activity of antioxidant enzymes, such as
glutathione peroxidase and superoxide dismutase Additionally,Maritim et al., (2003a, 2003b), in a review of the effects of STZ and
STZ plus antioxidant on the activity of antioxidant enzymes in animals
(mice and rats), had already reported that there is no total agreement
about the effects of diabetes on the activities of these enzymes.
Using one-way ANOVA it was possible to observe the statistical dif-
ferences among diabetic rats that received jaboticaba and the control
group, for each biomarker evaluated in this study. However, when
many responses are assessed, it is preferable to observe the results for
both oxidative stress biomarkers and animal groups simultaneously.
This would facilitate the visualization of the experimental results and
inferences about the supplementation of jaboticaba to STZ-induced dia-
betic rats could be easily drawn. In this work, a multivariate statistical
approach composed of principal component analysis was used to high-
light differences among groups receiving jaboticaba and the control
using nine biomarkers of oxidative stress. Using a two-dimensional
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657M.R. Alezandro et al. / Food Research International 54 (2013) 650–659plot (PC1 × PC2) more than 63% of the variability in the experimental
data could be explained by the proposed statistical approach, which is
a very interesting and desired fact once in vivo assays naturally present
a high variability within groups. Herein, the assessment of oxidative
stress of diabetic Wistar rats supplemented with jaboticaba using PCA
was highly effective.5. Conclusion
This study demonstrated that jaboticaba administration provided
beneﬁcial health effects in diabetic rats by improving lipid proﬁle and
reducing oxidative stress. Besides reducing water (8–14%) and energy
intake (6–13%), both doses of jaboticaba were responsible for decrease
in total cholesterol (32%) and triacylglycerol (50%), increase in the anti-
oxidant capacity of plasma (2–2.5 times) along with diminished lipid
peroxidation in plasma (22%) and brain (10–17%). The activity of theantioxidant enzymes SOD was increased in the brain, CAT and GPx in
the kidneys and liver, and GPx in plasma. The ﬁndings obtained here
support the recommendations for including at least ﬁve portions of
fruit and vegetables daily as part of a healthy diet, preventing develop-
ment or complications of non-transmissible chronic diseases. However,
further studies are essential to elucidate the exact mechanism of this
modulatory effect and also to evaluate the jaboticaba potential thera-
peutic effects.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.foodres.2013.07.041.Acknowledgments
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